Equine Viral Arteritis (EVA) - Case Confirmed
Defra has confirmed a case of EVA
Breeding restrictions have been put in place on the infected stallion and investigations have begun, to establish the likely origin of the infection, as well as any mares that may have been affected as well. The disease is being controlled in line with the industry agreed Horse Betting Levy Board (HBLB) Codes of Practice.
There are no human health implications associated with this disease.
What is EVA?
Equine Viral Arteritis (EVA) is a contagious disease caused by the equine arteritis virus (EVA). The virus occurs worldwide including mainland Europe.
There are no human health implications associated with this disease.
Equine Viral Arteritis (EVA) is a disease which is notifiable in the UK, by law under The Equine Viral Arteritis Order 1995 made under section 88 of the Animal Health Act 1981.Under the Order, anyone who owns, manages, inspects or examines a horse must notify their local Animal Health office when:
• they suspect the disease in a stallion, either on the basis of clinical signs or following blood or semen testing;
• they suspect disease, either on the basis of clinical signs or following blood testing, in a stallion or mare that has been mated or artificially inseminated within the past 14 days.
Full details of the exact notification requirements are in the EVA Order 1995.
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
